Double-Blind Naltrexone in Kleptomania

Inclusion Criteria: men and women age 21-75 current DSM-IV kleptomania. Exclusion Criteria: unstable medical illness or clinically significant abnormalities on prestudy laboratory tests or physical examination history of seizures myocardial infarction within 6 months current pregnancy or lactation, or inadequate contraception in women of childbearing potential clinically significant suicidality current or recent (past 3 months) DSM-IV substance abuse or dependence illegal substance within 2 weeks of study initiation initiation of psychotherapy or behavior therapy from a mental health professional for the treatment of kleptomania within 3 months prior to study baseline initiation of a psychotropic medication within 2 months prior to study inclusion previous treatment with naltrexone treatment with investigational medication or depot neuroleptics within 3 months, with fluoxetine within 6 weeks, or with other psychotropics within 2 weeks prior to study baseline.